The study determined the risk of hospitalization or death was 87% lower in study participants who were given remdesivir than participants who received a placebo.
from WebMD Health https://www.webmd.com/lung/news/20211223/remdesivir-hospital-covid?src=RSS_PUBLIC
0 Comments:
Post a Comment